Canada’s Drug Agency and the Canadian Institute for Health Information Sign Agreement to Improve Pharmaceutical Data
Canada's Drug Agency (CDA-AMC) and the Canadian Institute for Health Information (CIHI) have signed a 3-year agreement that will leverage the strengths of both organizations to build a stronger drug data and analytics foundation across Canada. This work will aim to advance CIHI’s Pharmaceutical Roadmap by collaborating with federal, provincial, and territorial governments, as well as other partners.